KLBF – Growth strategy across all business lines

KLBF – Growth strategy across all business lines Kalbe Farma (KLBF) is targeting growth across its prescription drugs, health products, nutrition, as well as distribution and logistics segments, with a focus on product innovation and strengthening collaboration with strategic partners. KLBF is also ensuring sufficient production capacity and mitigating foreign exchange volatility, particularly as some raw materials in the nutrition segment are still denominated in U.S. dollars. On the other hand, several medical device projects are nearing completion, including X-ray and dialyzer products, which have already entered the production phase, while the CT scan project is still under development in collaboration with GE Healthcare. (Source : Kontan)